BioWorld
www.bioworld.com/articles/493019

SPHINX'S PSORIASIS DRUG ENTERS PHASE II

Oct. 28, 1992

Sphinx Pharmaceuticals Corp. of Durham, N.C., said Tuesdaythat it has begun a Phase II clinical trial of its lead product,Kynac ointment, for treating the signs and symptoms ofpsoriasis.

(c) 1997 American Health Consultants. All rights reserved.